Gene · 5670
Papers3,544
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,544
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels. | Nat Cardiovasc Res | 2023 | 38076343 | PubTator, text mining | PubMed |
| Causal association of serum biomarkers with oral cavity and oropharyngeal cancer: a mendelian randomization study. | BMC Oral Health | 2023 | 38071306 | PubTator, text mining | PubMed |
| Case report: GCA like picture-preceding inaugural MOGAD presentation: A patient with a sudden-onset uniocular blindness. | Medicine (Baltimore) | 2023 | 38065923 | PubTator, text mining | PubMed |
| Down-regulation of EZH2 genes targeting RUNX3 affects proliferation, invasion, and metastasis of human colon cancer cells by Wnt/β-catenin signaling pathway. | Aging (Albany NY) | 2023 | 38048186 | PubTator, text mining | PubMed |
| Monoallelic deleterious MUTYH mutations generate colorectal cancer: A case report. | Clin Case Rep | 2023 | 38033687 | PubTator, text mining | PubMed |
| Drug-induced lung disease due to topical minoxidil. | Respir Med Case Rep | 2023 | 38025251 | PubTator, text mining | PubMed |
| Fetus In Fetu With Myelomeningocele. | Glob Pediatr Health | 2023 | 38024466 | PubTator, text mining | PubMed |
| Case Report: a rare primary gastric choriocarcinoma revealed on 18F-FDG PET/CT. | Front Oncol | 2023 | 38023162 | PubTator, text mining | PubMed |
| Potential biomarkers for predicting immune response and outcomes in lung cancer patients undergoing thermal ablation. | Front Immunol | 2023 | 38022658 | PubTator, text mining | PubMed |
Oral Anlotinib Maintenance Therapy for an Advanced Malignant Peritoneal Mesothelioma Diagnosed by Laparoscopy After Initial Misdiagnosis to Obtain Longer Progression-Free Survival: Case Report and Literature Review. | Onco Targets Ther | 2023 | 38021445 | PubTator, text mining | PubMed |
| Ovarian recurrence risk assessment using machine learning, clinical information, and serum protein levels to predict survival in high grade ovarian cancer. | Sci Rep | 2023 | 38016985 | PubTator, text mining | PubMed |
A prospective single-arm study on the relationship between dose-volume parameters of pelvic functional bone marrow and acute hematological toxicities during intensity-modulated radiotherapy with or without concurrent chemotherapy for uterine cervical/endometrial cancer. | Radiat Oncol | 2023 | 38012675 | PubTator, text mining | PubMed |
| Rectal Adenocarcinoma Presenting as a Cervical Mass: A Case Report. | Am J Case Rep | 2023 | 38011075 | PubTator, text mining | PubMed |
| State-of-the-Art Cancer Biology, Biodiagnostics and Therapeutics in Japan. | Biomedicines | 2023 | 38001906 | PubTator, text mining | PubMed |
| HER-2 Expression in Colorectal Cancer and Its Correlation with Immune Cell Infiltration. | Biomedicines | 2023 | 38001890 | PubTator, text mining | PubMed |
| The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management. | Cancers (Basel) | 2023 | 38001722 | PubTator, text mining | PubMed |
| Low-Grade Pseudomyxoma Peritonei Behaving as a High-Grade Disease: A Case Series and Literature Review. | Curr Oncol | 2023 | 37999146 | PubTator, text mining | PubMed |
| Advances in CAR T Cell Therapy for Non-Small Cell Lung Cancer. | Curr Issues Mol Biol | 2023 | 37998743 | PubTator, text mining | PubMed |
| Hepatocellular Carcinoma in Non-Fibrotic Liver: A Narrative Review. | Diagnostics (Basel) | 2023 | 37998562 | PubTator, text mining | PubMed |
| Metastases and treatment-resistant lineages in patient-derived cancer cells of colorectal cancer. | Commun Biol | 2023 | 37996567 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5670/papers?page=9